Anzeige
Mehr »
Sonntag, 27.07.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 936853 | ISIN: US28176E1082 | Ticker-Symbol: EWL
Tradegate
25.07.25 | 21:43
67,54 Euro
-0,84 % -0,57
Branche
Pharma
Aktienmarkt
S&P 500
1-Jahres-Chart
EDWARDS LIFESCIENCES CORPORATION Chart 1 Jahr
5-Tage-Chart
EDWARDS LIFESCIENCES CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
68,0068,2826.07.
67,8968,3225.07.

Aktuelle News zur EDWARDS LIFESCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
SaEdwards Lifesciences: RBC erhöht Kursziel aufgrund von Wachstumsaussichten2
SaEdwards Lifesciences: TD Cowen erhöht Kursziel auf 84 US-Dollar3
SaEdwards Lifesciences stock price target raised to $84 from $75 at TD Cowen3
SaEdwards Lifesciences stock price target raised to $89 at RBC on growth outlook6
FrEdwards Lifesciences Lifts 2025 Outlook On Strong First Half Performance2
FrEdwards Lifesciences Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Results12
EDWARDS LIFESCIENCES Aktie jetzt für 0€ handeln
Fr6 Analysts Assess Edwards Lifesciences: What You Need To Know6
FrEdwards Lifesciences raises 2025 sales growth outlook to 9-10% amid robust TAVR and TMTT momentum28
DoEdwards Lifesciences sales up nearly 12% in Q227
DoAfter-hours movers: Edwards Lifesciences, Intel, Deckers Brands and more10
DoEdwards Lifesciences rises on Q2 results beat, guidance raise21
DoEdwards Lifesciences Corp. Reports Retreat In Q2 Income323WASHINGTON (dpa-AFX) - Edwards Lifesciences Corp. (EW) reported earnings for second quarter that Drops, from the same period last yearThe company's bottom line totaled $333.2 million, or $0.56...
► Artikel lesen
DoEdwards Lifesciences Surges 8% On Hiked Guidance, Quarterly Beat14
DoEdwards Lifesciences Non-GAAP EPS of $0.67 beats by $0.05, revenue of $1.53B beats by $40M15
DoEdwards Lifesciences recalls certain arterial cannula products due to safety risk5
DiRobust TMTT Growth to Drive Edwards Lifesciences' Q2 Earnings14
MoEdwards Lifesciences files mixed shelf offering5
18.07.Should You Add Edwards Lifesciences Stock to Your Portfolio Now?13
09.07.Edwards Lifesciences stock rating maintained at Hold by Canaccord Genuity10
09.07.Edwards Lifesciences: Canaccord Genuity bestätigt "Halten"-Rating3
Weiter >>
81 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1